Daniel L Kisner - Net Worth and Insider Trading

Daniel L Kisner Net Worth

The estimated net worth of Daniel L Kisner is at least $123,368 dollars as of 2024-11-13. Daniel L Kisner is the Director of Zynerba Pharmaceuticals Inc and owns about 75,778 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $98,511. Daniel L Kisner is the Director of Dynavax Technologies Corp and owns about 1,500 shares of Dynavax Technologies Corp (DVAX) stock worth over $20,250. Daniel L Kisner is also the Director of Conatus Pharmaceuticals Inc and owns about 7,145 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $4,001. Besides these, Daniel L Kisner also holds Oncternal Therapeutics Inc (ONCT) . Details can be seen in Daniel L Kisner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel L Kisner has not made any transactions after 2023-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Daniel L Kisner

To

Daniel L Kisner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel L Kisner owns 7 companies in total, including Histogen Inc (HSTO) , Oncternal Therapeutics Inc (ONCT) , and Zynerba Pharmaceuticals Inc (ZYNE) among others .

Click here to see the complete history of Daniel L Kisner’s form 4 insider trades.

Insider Ownership Summary of Daniel L Kisner

Ticker Comapny Transaction Date Type of Owner
HSTO Histogen Inc 2014-02-07 director
ONCT Oncternal Therapeutics Inc 2020-07-21 director
ZYNE Zynerba Pharmaceuticals Inc 2023-06-14 director
LIMIT LIMIT 2013-10-30 director
LIMIT LIMIT 2012-07-30 director
LIMIT LIMIT 2015-01-01 director
LIMIT LIMIT 2004-05-14 director

Daniel L Kisner Latest Holdings Summary

Daniel L Kisner currently owns a total of 4 stocks. Among these stocks, Daniel L Kisner owns 75,778 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of June 14, 2023, with a value of $98,511 and a weighting of 79.85%. Daniel L Kisner owns 1,500 shares of Dynavax Technologies Corp (DVAX) as of October 30, 2013, with a value of $20,250 and a weighting of 16.41%. Daniel L Kisner also owns 7,145 shares of Conatus Pharmaceuticals Inc (CNAT) as of April 8, 2015, with a value of $4,001 and a weighting of 3.24%. The other 1 stocks Oncternal Therapeutics Inc (ONCT) have a combined weighting of 0.49% among all his current holdings.

Latest Holdings of Daniel L Kisner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYNE Zynerba Pharmaceuticals Inc 2023-06-14 75,778 1.30 98,511
DVAX Dynavax Technologies Corp 2013-10-30 1,500 13.50 20,250
CNAT Conatus Pharmaceuticals Inc 2015-04-08 7,145 0.56 4,001
ONCT Oncternal Therapeutics Inc 2020-07-21 500 1.21 605

Holding Weightings of Daniel L Kisner


Daniel L Kisner Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel L Kisner has made a total of 2 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 115 shares on June 14, 2023, which brought Daniel L Kisner around $40.

According to the SEC Form 4 filings, Daniel L Kisner has made a total of 0 transactions in Dynavax Technologies Corp (DVAX) over the past 5 years. The most-recent trade in Dynavax Technologies Corp is the acquisition of 1,000 shares on October 30, 2013, which cost Daniel L Kisner around $10,800.

According to the SEC Form 4 filings, Daniel L Kisner has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the acquisition of 4,000 shares on April 8, 2015, which cost Daniel L Kisner around $23,000.

More details on Daniel L Kisner's insider transactions can be found in the Insider Trading History of Daniel L Kisner table.

Insider Trading History of Daniel L Kisner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel L Kisner Trading Performance

GuruFocus tracks the stock performance after each of Daniel L Kisner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel L Kisner is -5.98%. GuruFocus also compares Daniel L Kisner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel L Kisner within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel L Kisner's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel L Kisner

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.35 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.57 LIMIT LIMIT LIMIT LIMIT LIMIT

Daniel L Kisner Ownership Network

Ownership Network List of Daniel L Kisner

No Data

Ownership Network Relation of Daniel L Kisner

Insider Network Chart

Daniel L Kisner Owned Company Details

What does Histogen Inc do?

Who are the key executives at Histogen Inc?

Daniel L Kisner is the director of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .

Histogen Inc (HSTO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Histogen Inc Insider Transactions

No Available Data

Daniel L Kisner Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel L Kisner. You might contact Daniel L Kisner via mailing address: 2292 Faraday Avenue, Carlsbad Ca 92008.